Illumina Raises 2026 Profit Outlook To $5.40-$5.45 A Share After Third Quarter Tops Its Own Guidance
The DNA-sequencing company also lifted its revenue forecast, and its third-quarter operating cash flow reached $419 million.
Illumina, the DNA-sequencing company, raised its 2026 revenue and earnings forecast after a third quarter that beat its own guidance, the company said in an earnings release Thursday. It now sees adjusted earnings of $5.40-$5.45 a share, up from $5.30-$5.40.
The raised outlook
Excluding tariff refunds, Illumina now expects 2026 revenue of $4.64-$4.66 billion, versus prior guidance of $4.60-$4.64 billion. Adjusted operating margin is seen at 23.6%, against a prior range of 23.4%-23.6%.
Organic revenue growth guidance is unchanged: greater than 4%, and greater than 5% for the rest of the world excluding Greater China, which the company excludes because of its place on China's Unreliable Entities List.
CEO Jacob Thaysen said "healthy clinical demand and robust NovaSeq X placements drove results above our guidance," and that continued momentum prompted the raise.
A quarter flattered by tariff refunds
Reported third-quarter revenue was $1.13 billion, up 4.2% from a year earlier. Standard-accounting earnings were $1.43 a share, versus $0.98 a year earlier; net income was $220 million, against $150 million.
Tariff refunds distort the picture. Illumina booked a $79 million benefit as a cut to cost of revenue, alongside a $37 million revenue reduction for the portion of refunds it expects to credit to customers. Stripping those out, revenue was $1.17 billion, adjusted operating margin was 25.0% and adjusted earnings were $1.44 a share, against $1.34 a year earlier.
Illumina makes sequencing and array-based technology used in research, clinical and applied markets.
Cash flow and balance sheet
Operating cash flow was $419 million, compared with $284 million a year earlier. Free cash flow, which subtracts $41 million of capital spending, was $378 million, up from $253 million.
The company ended the quarter with $1.34 billion in cash, cash equivalents and short-term investments. Term debt stood at $1.789 billion, with none due within the year, against $499 million that was current at the end of 2025.
Illumina's earnings call began at 4:30 p.m. ET Thursday, with a replay to be posted on its website for at least 30 days.
Sources
- 8-K Filing — ILLUMINA, INC. (ILMN) — SEC EDGAR
- Exhibit q326earningsrelease.htm — ILLUMINA, INC. 8-K exhibit — SEC EDGAR
- Illumina Non-GAAP EPS of $1.44 beats by $0.08, revenue of $1.13B misses by $20M (NASDAQ:ILMN) | Seeking Alpha — seekingalpha.com
- Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026 — prnewswire.com